# ODYY (Odyssey Health, Inc.) - SEC EDGAR Financial Statements

> Odyssey Health, Inc. reported $148K in total assets and a net loss of $5.73M through July 31, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ODYY
- Markdown: https://convexityos.com/fundamentals/ODYY.md
- SEC CIK: 0001626644
- Reporting currency: USD
- Latest filing period: July 31, 2026
- Last synced: Nov 21, 2026, 05:14 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001626644&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Jul 31, 2026 |
| Operating Income | FY 2026 | -$913K | Operating profit |
| Net Income | FY 2026 | -$5.73M | GAAP bottom line |
| Diluted EPS | FY 2026 | -$0.05 | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Jul 31, 2026 | $122K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| Research & Development | $0 | $23K | $55K | $170K | -- | $1.63M | $20K | $23.01M | -- | -- |
| **Operating Income** | -$913K | -$1.02M | -$2.14M | -$5.31M | -$8.11M | -$15.86M | -$3.85M | -$23.58M | -$420K | -$168K |
| **EBITDA** | -- | -- | -$2.14M | -$5.31M | -$8.10M | -$15.86M | -$3.84M | -$23.57M | -$410K | -$157K |
| Interest Expense | $1.58M | $253K | $518K | $614K | $836K | $1.07M | $502K | $70K | $63K | $30K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- | -- |
| **Net Income** | -$5.73M | -$1.74M | -$842K | -$5.92M | -$8.44M | -$16.88M | -$4.35M | -$23.43M | -$483K | -$198K |
| Basic EPS | -$0.05 | -$0.02 | -$0.01 | -$0.07 | -$0.09 | -$0.18 | -$0.05 | -$0.34 | $0.00 | $0.00 |
| **Diluted EPS** | -$0.05 | -$0.02 | -$0.01 | -$0.07 | -$0.09 | -$0.18 | -- | -- | -- | -- |
| Basic Shares Outstanding | 108.3M | 104.7M | 97.1M | 82.7M | 89.0M | 93.7M | 87.1M | 69.9M | 117.1M | 114.8M |
| Diluted Shares Outstanding | 108.3M | 104.7M | 97.1M | 82.7M | 89.0M | 93.7M | -- | -- | -- | -- |

### Income Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | -- | -- | -- | -- | $23K | $0 | $0 | $0 |
| **Operating Income** | -$130K | -$298K | -$182K | -$303K | -$156K | -$129K | -$157K | -$579K |
| **EBITDA** | -- | -- | -- | -- | -- | -$129K | -$157K | -$579K |
| Interest Expense | -- | $528K | $412K | $95K | $59K | $61K | $63K | $69K |
| **Net Income** | -$2.41M | $766K | -$3.60M | -$483K | -$252K | -$252K | -$220K | -$1.02M |
| Basic EPS | -- | $0.01 | -$0.03 | $0.00 | -- | $0.00 | $0.00 | -$0.01 |
| **Diluted EPS** | -- | $0.01 | -$0.03 | $0.00 | -- | $0.00 | $0.00 | -$0.01 |
| Basic Shares Outstanding | -- | 108.0M | 107.9M | 106.0M | -- | 104.7M | 104.7M | 104.7M |
| Diluted Shares Outstanding | -- | 186.7M | 107.9M | 106.0M | -- | 104.7M | 104.7M | 104.7M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $122K | $19K | $2.4K | $37K | $73K | $557K | $63K | $167K | $390 | $13K |
| **Cash & Short-Term Investments** | $122K | $19K | $2.4K | $37K | $73K | $557K | $63K | $167K | $390 | $13K |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $1.1K |
| **Total Current Assets** | $148K | $50K | $57K | $406K | $526K | $610K | $100K | $520K | $390 | $14K |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | $0 | $414 | $965 | $1.5K | $2.1K | $2.6K |
| Intangible Assets | -- | -- | $0 | $50K | $43K | $0 | $5.0K | $15K | $25K | -- |
| **Total Non-Current Assets** | $0 | $0 | $529K | $50K | $43K | $414 | $6.0K | $17K | $27K | $145K |
| **Total Assets** | $148K | $50K | $586K | $456K | $570K | $611K | $106K | $536K | $27K | $159K |
| Accounts Payable | $712K | $1.62M | $1.40M | $1.80M | $1.55M | $1.22M | $269K | $48K | $27K | $42K |
| Short-Term Debt | -- | -- | -- | -- | $1.18M | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $12.28M | $7.00M | $5.92M | $6.61M | $5.21M | $3.38M | $707K | $1.13M | -- | $579K |
| Long-Term Debt | -- | -- | -- | -- | -- | $0 | $50K | $0 | -- | -- |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $50K | $0 | -- | $0 |
| **Total Liabilities** | $12.28M | $7.00M | $5.92M | $6.61M | $5.21M | $3.38M | $757K | $1.13M | $847K | $579K |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | $1.18M | $0 | $50K | $0 | -- | -- |
| Common Stock | $106K | $97K | $97K | $79K | $78K | $87K | $89K | $87K | $61K | $115K |
| Retained Earnings | -$68.48M | -$62.75M | -$61.00M | -$60.10M | -$54.18M | -$45.73M | -$28.85M | -$24.50M | -$1.07M | -$590K |
| **Total Stockholders' Equity** | -$12.13M | -$6.95M | -$5.33M | -$6.16M | -$4.64M | -$2.77M | -$651K | -$594K | -$819K | -$420K |
| Total Equity | -$12.13M | -$6.95M | -$5.33M | -$6.16M | -$4.64M | -$2.77M | -$651K | -$594K | -$819K | -$420K |

### Balance Sheet (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $122K | $298K | $616K | $26K | $19K | $3.2K | $7.2K | $54K |
| **Cash & Short-Term Investments** | $122K | $298K | $616K | $26K | $19K | $3.2K | $7.2K | $54K |
| **Total Current Assets** | $148K | $374K | $721K | $144K | $50K | $67K | $108K | $183K |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $97K | $159K | $159K |
| **Total Assets** | $148K | $374K | $721K | $144K | $50K | $165K | $267K | $341K |
| Accounts Payable | $712K | $1.48M | $1.62M | $1.69M | $1.62M | $1.48M | $1.45M | $1.46M |
| **Total Current Liabilities** | $12.28M | $10.12M | $11.32M | $7.30M | $7.00M | $6.87M | $6.73M | $6.62M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | -- | $0 | $0 |
| **Total Liabilities** | $12.28M | $10.12M | $11.32M | $7.30M | $7.00M | -- | $6.73M | $6.62M |
| Common Stock | $106K | $101K | $100K | $100K | $97K | $97K | $97K | $97K |
| Retained Earnings | -$68.48M | -$66.07M | -$66.83M | -$63.23M | -$62.75M | -$62.49M | -$62.24M | -$62.02M |
| **Total Stockholders' Equity** | -$12.13M | -$9.75M | -$10.60M | -$7.16M | -$6.95M | $6.70M | -$6.46M | -$6.28M |
| Total Equity | -$12.13M | -$9.75M | -$10.60M | -$7.16M | -$6.95M | $6.70M | -$6.46M | -$6.28M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.73M | -$1.74M | -$842K | -$5.92M | -$5.92M | -$8.44M | -$4.35M | -$23.43M | -$483K | -$198K |
| Depreciation & Amortization | -- | -- | $1.5K | $3.4K | $3.4K | $2.4K | $11K | $11K | $11K | $11K |
| Stock-Based Compensation | $5.4K | $108K | $578K | $2.82M | -- | -- | $2.78M | $101K | $0 | -- |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $17K |
| Change in Payables | -$144K | $215K | -$196K | $248K | $248K | $325K | $222K | $21K | $48K | $11K |
| **Operating Cash Flow** | -$1.05M | -$347K | -$1.22M | -$1.47M | -$1.47M | -$3.18M | -$649K | -$105K | -$146K | -$117K |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$117K |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Investing Cash Flow** | $0 | $70K | $1.00M | -$10K | -- | $0 | $0 | $0 | $0 | $0 |
| Common Stock Issued | -- | $0 | $56K | $580K | $580K | $2.47M | $0 | -- | -- | -- |
| **Financing Cash Flow** | $1.15M | $294K | $181K | $1.45M | $1.45M | $2.74M | $545K | $272K | $133K | $128K |
| **Net Change in Cash** | $103K | $17K | -$34K | -$36K | -$36K | -$484K | -$104K | $167K | -$13K | $11K |

### Cash Flow Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.41M | $766K | -$3.60M | -$483K | -$252K | -$252K | -$220K | -$1.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| Stock-Based Compensation | $5.4K | $0 | $0 | $0 | $0 | $12K | $36K | $60K |
| Change in Payables | -$99K | -$50K | -$69K | $73K | $25K | -$5.6K | $14K | $182K |
| **Operating Cash Flow** | -$160K | -$319K | -$284K | -$284K | -$48K | -$4.0K | -$47K | -$249K |
| Common Stock Issued | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | -$16K | $0 | $875K | $290K | -$5.7K | $0 | $0 | $300K |
| **Net Change in Cash** | -$175K | -$319K | $591K | $6.5K | $16K | -$4.0K | -$47K | $51K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -3875.1% | -3504.8% | -143.7% | -1298.7% | -1482.3% | -2765.3% | -4118.9% | -4367.5% | -1759.4% | -124.2% |
| Current Ratio | 0.01x | 0.01x | 0.01x | 0.06x | 0.10x | 0.18x | 0.14x | 0.46x | -- | 0.03x |
| Quick Ratio | 0.01x | 0.00x | 0.00x | 0.01x | 0.01x | 0.16x | 0.09x | 0.15x | -- | 0.03x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -- | -- | -100.0% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -100.0% |
| 5Y Revenue / Share Growth | -- | -- | -- | -- | -- | -- | -100.0% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -212.3% | -- | -- |
| Return on Assets (ROA) | -3875.1% | -955.4% | -636.2% | -840.6% | -3504.8% | -8650.2% | -5553.7% | -388.0% |
| Current Ratio | 0.01x | 0.04x | 0.06x | 0.02x | 0.01x | 0.01x | 0.02x | 0.03x |
| Quick Ratio | 0.01x | 0.03x | 0.05x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -165.6% | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -101.7% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -100.0% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
